The Company was acquired by Strathspey Crown Holdings Group, LLC in 2013 and subsequently by its subsidiary, Alphaeon Corporation ("Alphaeon"), by means of a stock purchase agreement ("Stock Purchase…
The Company was acquired by Strathspey Crown Holdings Group, LLC in 2013 and subsequently by its subsidiary, Alphaeon Corporation ("Alphaeon"), by means of a stock purchase agreement ("Stock Purchase…
In February 2021, the Company settled the certain litigation with Medytox, Inc. (‘Medytox”) related to Jeuveau ® by means of settlement and license agreements (the "Medytox Settlement Agreements").
Evolus, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
EOLS-DEBT-9324
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2022-12-31.
EOLS-DEBT
Debt stack $164.9M
90%
Market cache reports total debt of $164.9M.
Evolus, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Evolus, Inc..
Evolus, Inc. Ownership
Holder
Name
Confidence
Evidence
EOLS-OWNER-NANTAHALA-CAPITAL-MANAGEMENT-LLC
Nantahala Capital Management, LLC
90%
13F overlay lists Nantahala Capital Management, LLC as top holder; 149 tracked holders.
Evolus, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.